Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with glycine-site partial agonist properties. Rapastinel Trifluoroacetate has the potential for major depressive disorder treatment.
|Storage||Desiccate at -20°C
||Shipping Condition||Room temperature in continental US; may vary elsewhere.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).